End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5 EUR | +25.00% | -16.67% | -58.33% |
2023 | Vitruvia Medical AG Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
2022 | Vitruvia Medical AG announced that it expects to receive CHF 2.2 million in funding | CI |
Sales 2021 | 1.97M 2.11M 168M | Sales 2022 | 1.53M 1.63M 131M | Capitalization | 4.07M 4.36M 348M |
---|---|---|---|---|---|
Net income 2021 | -8M -8.57M -685M | Net income 2022 | -1M -1.07M -85.58M | EV / Sales 2021 | 14.4 x |
Net cash position 2021 | 48.93K 52.43K 4.19M | Net Debt 2022 | 843K 904K 72.15M | EV / Sales 2022 | 3.22 x |
P/E ratio 2021 * |
-
| P/E ratio 2022 |
-2.62
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 0% |
1 day | +25.00% | ||
1 week | -16.67% | ||
Current month | -45.65% | ||
1 month | -45.65% | ||
3 months | -34.21% | ||
6 months | -28.57% | ||
Current year | -58.33% |
Managers | Title | Age | Since |
---|---|---|---|
Claus Wiest
CEO | Chief Executive Officer | - | - |
Chairman | - | 31/10/17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | - | 31/10/17 | |
Robert P. Sieber
BRD | Director/Board Member | - | - |
Date | Price | Change |
---|---|---|
26/04/24 | 0.5 | +25.00% |
25/04/24 | 0.4 | 0.00% |
24/04/24 | 0.4 | -20.00% |
23/04/24 | 0.5 | 0.00% |
22/04/24 | 0.5 | -16.67% |
End-of-day quote BOERSE MUENCHEN, April 25, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-58.33% | 1.23M | |
+4.36% | 32.47B | |
+15.70% | 7.45B | |
+22.93% | 3.89B | |
-16.29% | 3.17B | |
-25.96% | 1.28B | |
-36.14% | 1.09B | |
-35.42% | 902M | |
-0.13% | 893M | |
-24.12% | 857M |
- Stock Market
- Equities
- 991 Stock